Proxy Votes Now

Home › Funds › GMO › GMO Benchmark-Free Fund

GMO Benchmark-Free Fund (GBFFX) proxy voting record 2025-2026

Fund family: GMO · Filed by GMO TRUST (CIK 772129) · SEC series S000033464

Ticker: GBFFX (C000102896)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 10,895 with, 259 against, 45 abstentions (not counted as with management); 236 items carried no recommendation; 1 split votes are in neither count. Shareholder proposals: 102 FOR, 214 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with GMO as a whole

The same two figures as GMO’s manager page (51,210 ballot items across 26 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsGMOItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)90.6%9,06091.3%40,970
Backed environmental and social shareholder proposals at US companies9.3%5410.3%369

Where this fund voted differently from most GMO funds

Each ballot item this fund voted is set against the votes of the other GMO funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most GMO funds on all 4,923 items where a comparison was possible.

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5,70830
Corporate Governance2,045102
Capital Structure1,37413
Compensation1,26621
Audit-related6200
Say-on-Pay1200
Other820
Extraordinary Transactions771
Other Social Issues5924
Environment or Climate5251

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Rio Tinto PlcMay 6, 2026$4M210
Target CorporationJune 10, 2026$3M183
Pfizer Inc.April 23, 2026$3M161
Verizon Communications Inc.May 21, 2026$3M153
General Motors CompanyJune 2, 2026$3M172
Citigroup Inc.May 20, 2026$3M160
Regeneron Pharmaceuticals, Inc.June 12, 2026$3M70
Johnson & JohnsonApril 23, 2026$3M151

Notable votes against management

MeetingCompanyProposalFundMgmt
June 10, 2026Target CorporationShareholder proposal requesting policy requiring the Board Chair to be an independent director. Shareholder proposalForAgainst
June 10, 2026Target CorporationShareholder proposal requesting a report on presence of pesticides in Target's private label brands. Shareholder proposalForAgainst
April 23, 2026Pfizer Inc.Adopt an Independent Chair Policy Shareholder proposalAgainstFor
May 21, 2026Verizon Communications Inc.Board oversight of material issues related to climate change Shareholder proposalAgainstFor
May 21, 2026Verizon Communications Inc.Independent board chair Shareholder proposalAgainstFor
June 2, 2026General Motors CompanyShareholder Proposal Regarding Separation of Chair and CEO Roles Shareholder proposalAgainstFor
June 2, 2026General Motors CompanyShareholder Proposal Requesting a Report on Human Rights Standards for Indigenous Peoples Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
March 17, 2026QUALCOMM IncorporatedStockholder proposal entitled "Shareholder Ability to Call for a Special Meeting." Shareholder proposalForAgainst
March 17, 2026QUALCOMM IncorporatedStockholder proposal entitled "Report on Risk of China Exposure." Shareholder proposalAgainstFor
April 22, 2026The Cigna GroupShareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposalAgainstFor
May 13, 2026Elevance Health, Inc.Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposalAgainstFor

Search this fund’s votes by company

11,441 ballot items at 944 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, GMO Benchmark-Free Fund (GBFFX) voted at 944 shareholder meetings of 854 companies, on 11,441 ballot items in all. Where management made a recommendation, the fund followed it on 97.3% of the items and voted against it 259 times. Its most frequent area of disagreement was corporate governance (102 of its votes against management). It voted FOR 32.3% of the 316 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than GMO's funds as a whole (90.6% against 91.3%). It voted the same way as most GMO funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of GMO’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.